G2B-10286-95140
2 vaccinations
1 coded response
2 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 296 / SC
- Registered
- 2021-10-10
- Relationship
- Child or adolescent in my care
- Guardian
- PDQ-79580-39022
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-10
Dose 1 — Pfizer-BioNTech
-
2021-05-31
Dose 2 — Pfizer-BioNTech
-
2021-10-10
Registered in v-safe
-
2021-11-29
Survey response — 6 months, dose 2, dependentMedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVID-19MedDRA releases: 2024-11 · check-in free text available
-
2021-11-29
Report sent to call center — 6 months, dose 2, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-11-30
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-06-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-10 | Pfizer-BioNTech | No |
| 2 | 2021-05-31 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 10 — 6 months, dose 2, dependent
Symptoms: COVID-19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release